- Veri Yok
Türkçe
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Scientists at the Technical University of Munich have made significant progress in measuring the Earth's rotation with unprecedented accuracy. Now, the ring laser from the Wettzell Geodetic Observatory can be used to capture data at a quality level unmatched anywhere in the world. These measurements are crucial for determining the position of the Earth in space, assisting climate research, and imp...
The China International Industrial Expo is an important window and economic and trade exchange and cooperation platform for China's industrial sector to the world, as well as a window for the world to understand the current development status of China's manufacturing industry. It is understood that the scale, energy level, and number of new exhibits of this year's Industrial Expo are all the highe...
Recently, Professor Tsumoru Shintake from Okinawa University of Science and Technology (OIST) proposed a revolutionary extreme ultraviolet (EUV) lithography technology that not only surpasses the boundaries of existing semiconductor manufacturing, but also heralds a new chapter in the industry's future.This innovation significantly improves stability and maintainability, as its simplified design o...
It is reported that researchers from Foshan University, the Institute of Chemical Defense of the Academy of Military Sciences, the National Defense Technology Key Laboratory of Equipment Remanufacturing Technology of the Armored Forces Academy, and Chengdu State owned Jinjiang Machinery Factory have summarized and reported the latest progress of machine learning in defect detection and prediction ...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...